Atypical BRAF Alterations – CMed

People with Advanced Malignancies Harboring MEK or Atypical BRAF Alterations are asked to participate in a research study being conducted by Montefiore Medical Center.

You may be eligible to participate in this study if you:

  • Are a male or female at least 18 years of age
  • Have a locally advanced or metastatic malignancy
  • Have adequate renal, hepatic, cardiac, and bone marrow function
  • Have a tumor harboring a MEK or atypical BRAF alteration

You may NOT participate in this study if you:

  • Have Gastrointestinal (GI) condition that could impair absorption of study medication
  • Have known uncontrolled brain metastases
  • Have had major surgery within 4 weeks prior to first dose.
  • Have received any cancer-directed therapy
  • Have any evidence of serious active infections
  • Are pregnant or breastfeeding

Contact Information
Mohammad Ghalib, Study Coordinator
1695 Eastchester Road, 2nd floor
Bronx, NY 10461
Phone: (718) 405-8515